SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about loss of share certificate

28 Oct 2020 Evaluate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sanofi India has informed that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s) from the shareholder(s), Prema S Rao (Certificate No: 5497), H Sachidananda Rao (Certificate No: 53886). Further details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3493.20 23.65 (0.68%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×